As genetic testing is becoming more prevalent and more women are being diagnosed with hereditary cancer syndromes many are trying to assume some control over their genetic destinies. Some women with mutations such as Lynch syndrome or BRCA are undergoing prophylactic surgeries, which are done in order to prevent cancer from developing in specific body parts.
Suresh S. Ramalingam, a professor of medical oncology at the Winship Cancer Institute of Emory University, comments on the difference in toxicities associated with immunotherapy.
I have a "usually" when it comes to cancer? How could anything ever be usual about cancer? Am I nuts?
Former U.S. president Jimmy Carter provided an update on his health today in a press conference, announcing that he has melanoma.
The FDA has approved Adcetris as a consolidation therapy following autologous stem cell transplantation in patients with Hodgkin lymphoma at risk of relapse or progression, based on the phase 3 AETHERA trial.
An analysis of data collected on thousands of ovarian cancer patients in California turned up some promising news for women with this diagnosis.
Low-grade gliomas may be classified into three distinct prognostic categories based on genomic data.
Adjuvant whole brain radiation therapy (WBRT) dramatically increases the incidence of cognitive decline without survival benefit in patients with small brain metastases from other tumor types.
The investigational agent venetoclax has successfully met the primary endpoint of a phase 2 study as a treatment for patients with high-risk relapsed or refractory chronic lymphocytic leukemia.
A phase 3 trial has demonstrated that treatment with telotristat etiprate can effectively lower the average number of daily bowel movements for individuals with carcinoid syndrome.
Fear of death and dying is explored by a two-time cancer survivor. There are benefits to taking a moment to look at these fears today.
For improved physical function, begin rehab prior to cancer surgery.
Embarking on the genetic testing process can be a toss-up for patients who have cancer or face an elevated risk of developing the disease.
While it's clear that cancer immunotherapies can be very expensive, there is help available to patients when it comes to deciding whether to take such treatments.
As a lung cancer survivor and advocate for current patients, I have always been outspoken about the need for greater lung cancer awareness.
Kevin gets philosophical, sharing deeply wrought insights in a manner that, just possibly, might actually make sense
A new study has uncovered notable disparities in uptake of adjuvant breast cancer therapies in the Appalachian region of the United States, a finding that suggests targeted intervention strategies may help to improve outcomes for this population of women.
Oncology clinicians and practices need to do a better job of engaging patients more fully in their care planning and make patient-reported outcomes an integral part of cancer treatment research.
People want to help, so go ahead and ask for help. Cancer is not a one-person job.
New Year's Resolutions tend to get lost in the shuffle as the year progresses. Looking back at my list, halfway through the year, I see my cancer fighting soldiers are still in my corner.
Maurie Markman urges patients with ovarian cancer who have undergone surgery to speak with their gynecologic oncologist and see if IP therapy is right for them.
Illness is a solitary endeavor, but you still need people to ground you and give you strength as you move through it and face tests, treatments and recovery.
New diagnoses of prostate cancer have declined nearly 30 percent, a study has found, since the U.S. Preventive Services Task Force discouraged the routine use of prostate-specific antigen testing in 2011.
Taking flu shots and other preventive vaccines before cancer treatment is a good idea, but patients should know when to pursue the injections and when to hold off.
